Molecular analysis of bladder cancer helps to improve our understanding of tumour biology and identify several therapeutic targets, such as programmed death 1 (PD‐1) and programmed cell death ligand 1 (PD‐L1).5 Here, CD274 is linked to urinary bladder carcinoma.